Metformin use in infertile patients with polycystic ovary syndrome: An evidence-based overview

Reproductive BioMedicine Online

Volumn 16, Issue 3, 2008, Pages 327-335

  Palomba, Stefano ^a   Oppedisano, Rosamaria ^a   Tolino, Achille ^b   Orio, Francesco ^c   Zullo, Fulvio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

Anovulation; Fertility; Insulin; Metformin; Ovulation induction; Polycystic ovary syndrome

Indexed keywords

CLOMIFENE CITRATE; FLUTAMIDE; GONADOTROPIN; INOSITOL TRISPHOSPHATE 3 KINASE; METFORMIN; PLACEBO; PROTEIN KINASE B; ROSIGLITAZONE; SEX HORMONE BINDING GLOBULIN; VASCULOTROPIN; ANTIDIABETIC AGENT;

ANDROGEN SYNTHESIS; ANOVULATION; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIATHERMY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; EVIDENCE BASED MEDICINE; GLUCONEOGENESIS; GLUCOSE METABOLISM; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LAPAROSCOPIC SURGERY; MULTIPLE CYCLE TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVARY HYPERSTIMULATION; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PHOSPHORYLATION; REVIEW; FEMALE; FEMALE INFERTILITY; META ANALYSIS; METHODOLOGY; OVARY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

FEMALE; GONADOTROPINS; HUMANS; HYPOGLYCEMIC AGENTS; INFERTILITY, FEMALE; INSULIN RESISTANCE; META-ANALYSIS AS TOPIC; METFORMIN; OVARY; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 41049105848     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60592-5     Document Type: Article

References (59)

1. Adashi EY, Hsueh AJ, Yen SS 1981 Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology 108, 1441-1449.
2. Arslanian SA, Lewy V, Danadian K, Saad R 2002 Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. Journal of Clinical Endocrinology and Metabolism 87, 1555-1559.
3. Bailey CJ, Turner RC 1996 Metformin. New England Journal of Medicine 334, 574-579.
4. Beck JI, Boothroyd C, Proctor M et al. 2005 Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation. Cochrane Database Systemic Reviews 1, CD002249.
5. Branigan EF, Estes MA 2003 A randomized clinical trial of treatment of clomiphene citrate-resistant anovulation with the use of oral contraceptive pill suppression and repeated clomiphene citrate treatment. American Journal of Obstetrics and Gynecology 188, 1424-1430.
6. Costello MF, Chapman M, Conway U 2006 A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome. Human Reproduction 21, 1387-1399.
7. Costello M, Shrestha B, Eden J et al. 2007a Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome. Cochrane Database of Systemic Reviews 2007 1, CD005552.
8. Costello MF, Shrestha B, Eden J 2007b Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review. Human Reproduction 22, 1200-1209.
9. De Leo V, Lanzetta D, D'Antona D et al. 1998 Hormonal effects of flutamide in young women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 83, 99-102.
10. Diamanti-Kandarakis E, Kouli CR et al. 1999 A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. Journal of Clinical Endocrinology and Metabolism 84, 4006-4011.
11. Doronzo G, Russo I, Mattiello L et al. 2004 Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance. European Journal of Clinical Investigation 34, 664-673.
12. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis Endocrine Review 18, 774-800.
13. Dunaif A, Segal KR, Futterweit W et al. 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38, 1165-1174.
14. Ehrmann DA 2005 Polycystic ovary syndrome. New England Journal of Medicine 352, 1223-1236.
15. Fantus IG, Brosseau R 1986 Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo. Journal of Clinical Endocrinology and Metabolism 63, 898-905.
16. Franks S, Mason H, White D et al. 1998 Etiology of anovulation in polycystic ovary syndrome. Steroids 63, 306-307.
17. Fulghesu AM, Villa P, Pavone V et al. 1997 The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 82, 644-648.
18. George SS, George K, Irwin C et al. 2003 Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial. Human Reproduction 18, 299-304.
19. Gilbert C, Valois M, Koren G 2006 Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertility and Sterility 86, 658-663.
20. Hughes E, Collins J, Vandekerckhove P et al. 2000 Clomiphene citrate for ovulation induction in women with oligo-amenorrhoea. Cochrane Database Systemic Reviews 2 CD000056.
21. Hwu YM, Lin SY, Huang WY et al. 2005 Ultra-short metformin pretreatment for clomiphene citrate-resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics 90, 39-43.
22. Kashyap S, Wells GA, Rosenwaks Z 2004 Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome. Human Reproduction 19, 2474-2483.
23. Khattab S, Fotouh IA, Mohesn IA et al. 2006. Use of metformin for prevention of ovarian hyperstimulation syndrome: a novel approach. Reproductive BioMedicine Online 13, 194-197.
24. Khorram O, Helliwell JP, Katz S et al. 2006 Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome. Fertility and Sterility 85, 1448-1451.
25. Kjøotrøod SB, von Düring V, Carlsen SM 2004 Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study. Human Reproduction 19, 1315-1322.
26. Knochenhauer ES, Key TJ, Kahsar-Miller M et al. 1998 Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. Journal of Clinical Endocrinology and Metabolism 83, 3078-3082.
27. Legro RS, Barnhart HX, Schlaff WD et al. Cooperative Multicenter Reproductive Medicine Network 2007 Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. New England Journal of Medicine 356, 551-566.
28. Levri KM, Slaymaker E, Last A et al. 2005 Metformin as treatment for overweight and obese adults: a systematic review. Annals of Family Medicine 3, 457-461.
29. Lord JM, Flight IH, Norman RJ 2003a Metformin in polycystic ovary syndrome: systematic review and meta-analysis. British Medical Journal 327, 951-953.
30. Lord JM, Flight IH, Norman RJ 2003b Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiroinositol) for polycystic ovary syndrome. Cochrane Database Systemic Reviews 3, CD003053
31. Matthaei S, Hamann A, Klein HH et al. 1991 Association of metformin's effect to increase insulin-stimulated glucose transport with potentiation of insulin-induced translocation of glucose transporters from intracellular pool to plasma membrane in rat adipocytes. Diabetes 40, 850-857.
32. Moll E, Bossuyt PM, Korevaar JC et al. 2006 Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. British Medical Journal 332, 1485.
33. Nestler JE, Jakubowicz DJ, de Vargas AF et al. 1998a Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositol glycan mediators as the signal transduction system. Journal of Clinical Endocrinology and Metabolism 83, 2001-2005.
34. Nestler JE, Jakubowicz DJ, Evans WS et al. 1998b. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. New England Journal of Medicine 338, 1876-1880.
35. Pache TD, de Jong FH, Hop WC et al. 1993 Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome. Fertility and Sterility 59, 544-599.
36. Palomba S, Zullo F 2006 Ovulation induction in infertile patients with polycystic ovary syndrome. Minerva Ginecologica 58, 115-135.
37. Palomba S, Orio F Jr, Nardo LG et al. 2004 Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 89, 4801-4809.
38. Palomba S, Orio F Jr, Falbo A et al. 2005a Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 90, 4068-4074.
39. Palomba S, Orio F Jr, Falbo A et al. 2005b Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome. Clinical Endocrinology 63, 631-435.
40. Palomba S, Falbo A, Orio F Jr et al. 2005c A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. Human Reproduction 20, 2879-2886.
41. Plymate SR, Jones RE, Matej LA et al. 1988 Regulation of sex hormone binding globulin (SHBG) production in Hep G2 cells by insulin. Steroids 52, 339-340.
42. Poretsky L, Kalin MF 1987 The gonadotropic function of insulin. Endocrine Review 8, 132-141.
43. Practice Committee of the American Society for Reproductive Medicine 2003 Ovarian hyperstimulation syndrome. Fertility and Sterility 80, 1309-1314.
44. Pryor PR, Liu SC, Clark AE et al. 2000 Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin. Biochemical Journal 348, 83-91.
45. Rice S, Christoforidis N, Gadd C et al. 2005 Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Human Reproduction 20, 373-381.
46. Rouzi AA, Ardawi MS 2006 A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome. Fertility and Sterility 85, 428-435.
47. Sahin Y, Yirmibes U, Kelestimur F et al. 2004 The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome. European Journal of Obstetrics, Gynecology and Reproductive Biology 113, 214-220.
48. Siebert TI, Kruger TF, Steyn DW et al. 2006 Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review. Fertility and Sterility 86, 1432-1437.
49. Stumvoll M, Nurjhan N, Perriello G et al. 1995 Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. New England Journal of Medicine 333, 550-554.
50. Sturrock ND, Lannon B, Fay TN 2002 Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice. British Journal of Clinical Pharmacology 53, 469-473.
51. Tang T, Barth JH, Balen AH 2005 The use of metformin for women with PCOS undergoing IVF treatment. Human Reproduction 20, 17-18.
52. Tang T, Glanville J, Orsi N et al. 2006 The use of metformin for women with PCOS undergoing IVF treatment. Human Reproduction 21, 1416-1425.
53. Ulloa-Aguirre A, Portocarrero L, Zariñán T et al. 2006. Effects of metformin on inappropriate LH release in women with polycystic ovarian syndrome and insulin resistance. Reproductive BioMedicine Online 12, 669-683.
54. van Santbrink EJ, Hohmann FP, Eijkemans MJ et al. 2005 Does metformin modify ovarian responsiveness during exogenous FSH ovulation induction in normogonadotrophic anovulation? A placebo-controlled double-blind assessment. European Journal of Endocrinology 152, 611-617.
55. Velasquez E, Mendoza S, Hamer T et al. 1994 Metformin therapy in polycystic ovarian syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism: Clinical and Experimental 43, 647-654.
56. Vendola KA, Zhou J, Adesanya OO et al. 1998 Androgens stimulate early stages of follicular growth in the primate ovary. Journal of Clinical Investigation 101, 2622-2629.
57. Welt CK, Gudmundsson JA, Arason G et al. 2006 Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. Journal of Clinical Endocrinology and Metabolism 91, 4842-4848.
58. Willis DS, Watson H, Mason HD et al. 1998 Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. Journal of Clinical Endocrinology and Metabolism 83, 3984-3991.
59. Wu XK, Zhou SY, Liu JX et al. 2003 Selective ovary resistance to insulin signalling in women with polycystic ovary syndrome. Fertility and Sterility 80, 954-965.